Takeda Pharmaceuticals America, Inc. (TAK) Lobbying Data
TAK lobbying summary
Takeda Pharmaceuticals America, Inc. (TAK) has reported $35.6M in federal lobbying spending across 165 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Medicare/Medicaid, Taxation, Budget/Appropriations. Lobbying firms used include Takeda Pharmaceuticals America, Inc., Crossroads Strategies, LLC, Porterfield, Fettig & Sears, LLC.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2025 | $6.6M |
| 2024 | $4.1M |
| 2023 | $5.7M |
| 2022 | $4.9M |
| 2021 | $8.1M |
| 2020 | $6.2M |
See insider trading for TAK or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.